Showing 2 posts of 2 posts found.
Pharma companies were able to negotiate far fewer so-called ‘pay to delay’ cases as a strategy to stave off generic …
The Japan-based drugmaker Daiichi Sankyo is to cut up to 1,200 jobs – or about half its workforce – in …
Capital Dynamics invests €14m in Italian community healthcare platform CareHub
Medtronic secures CE Mark for new cardiac pacing portfolio
Dermatology leader Doncker is new Onicor CEO
East London pharmacies pilot cholesterol-lowering injections to cut waiting times
Weber is new CMO at Sensorion